跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
拉莫三嗪分散片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Lamotrigine Dispersible Tablets
Approved
化学药品
Lamotrigine Dispersible Tablets
WELLCOME FOUNDATION LIMITED(THE)
🇨🇳 National Medical Products Administration
Approval Date
May 5, 2019
Approval ID
7uctIgVzc6c
Company
WELLCOME FOUNDATION LIMITED(THE)
Type
化学药品
Approval Details
Approval Id
7uctIgVzc6c
Approval Number
H20190034
Generic Name
拉莫三嗪分散片
Generic Name En
Lamotrigine Dispersible Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
2mg
Reg Date
2019-05-05
Expired Date
2024-05-04
Company Name
WELLCOME FOUNDATION LIMITED(THE)
Company Address
980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
Production Company Name
GLAXOSMITHKLINE LLC
Production Company Address
1011 Arendell Avenue, Zebulon, North Carolina, 27597, United states of America
Company Detail Path
/organization/wellcome-foundation-limited-the
Production Company Detail Path
/organization/glaxosmithkline-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 5, 2019
Approval ID
7uctIgVzc6c
Type
化学药品
Back to NMPA Approvals